These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15198427)

  • 41. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
    Thomasin C; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
    Ruan G; Feng SS; Li QT
    J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres.
    Cohen S; Yoshioka T; Lucarelli M; Hwang LH; Langer R
    Pharm Res; 1991 Jun; 8(6):713-20. PubMed ID: 2062800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.
    Pistel KF; Kissel T
    J Microencapsul; 2000; 17(4):467-83. PubMed ID: 10898087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis.
    Lacasse FX; Filion MC; Phillips NC; Escher E; McMullen JN; Hildgen P
    Pharm Res; 1998 Feb; 15(2):312-7. PubMed ID: 9523320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of FITC-albumin encapsulated poly(DL-lactide-co-glycolide) microspheres and its release characteristics.
    Sun SW; Jeong YI; Jung SW; Kim SH
    J Microencapsul; 2003; 20(4):479-88. PubMed ID: 12851048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.
    Huang Z; Chen X; Fu H; Wen X; Ma C; Zhang J; Wu C; Huang Y; Pan X; Wu C
    J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D; Alonso MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein encapsulation in biodegradable amphiphilic microspheres.
    Bouillot P; Ubrich N; Sommer F; Duc TM; Loeffler JP; Dellacherie E
    Int J Pharm; 1999 Apr; 181(2):159-72. PubMed ID: 10370212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled release carriers of growth factors FGF-2 and TGFbeta1: synthesis, characterization and kinetic modelling.
    Kalaji N; Deloge A; Sheibat-Othman N; Boyron O; About I; Fessi H
    J Biomed Nanotechnol; 2010 Apr; 6(2):106-16. PubMed ID: 20738064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A simple technique for development of fibres with programmable microsphere concentration gradients for local protein delivery.
    Mehrpouya F; Yue Z; Romeo T; Gorkin R; Kapsa RMI; Moulton SE; Wallace GG
    J Mater Chem B; 2019 Jan; 7(4):556-565. PubMed ID: 32254789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and characterization of poly(lactic acid-co-glycolic acid) complex microspheres as drug carriers.
    Wang F; Liu X; Yuan J; Yang S; Li Y; Gao Q
    J Biomater Appl; 2016 Oct; 31(4):544-552. PubMed ID: 27368752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.